Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521024 | SCV000621922 | uncertain significance | not provided | 2017-11-06 | criteria provided, single submitter | clinical testing | The R174C variant in the CLPP gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R174C variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The R174C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Arginine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R174C as a variant of uncertain significance. |
Fulgent Genetics, |
RCV002497036 | SCV002784556 | uncertain significance | Perrault syndrome 3 | 2021-09-03 | criteria provided, single submitter | clinical testing | |
Undiagnosed Diseases Network, |
RCV002497036 | SCV004812033 | pathogenic | Perrault syndrome 3 | 2023-01-31 | no assertion criteria provided | clinical testing |